BioVie's market cap is currently $14.39M. The company's EPS TTM is $-3.952; its P/E ratio is ―; BioVie is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
